mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0005 |